Journal of Immunology 2015-01-15

The orientation of HIV-1 gp120 binding to the CD4 receptor differentially modulates CD4+ T cell activation.

Kathrin Zimmermann, Thomas Liechti, Anna Haas, Manuela Rehr, Alexandra Trkola, Huldrych F Günthard, Annette Oxenius

Index: J. Immunol. 194(2) , 637-49, (2015)

Full Text: HTML

Abstract

Progressive quantitative and qualitative decline of CD4(+) T cell responses is one hallmark of HIV-1 infection and likely depends on several factors, including a possible contribution by the HIV-1 envelope glycoprotein gp120, which binds with high affinity to the CD4 receptor. Besides virion-associated and cell-expressed gp120, considerable amounts of soluble gp120 are found in plasma or lymphoid tissue, predominantly in the form of gp120-anti-gp120 immune complexes (ICs). Because the functional consequences of gp120 binding to CD4(+) T cells are controversially discussed, we investigated how gp120 affects TCR-mediated activation of human CD4(+) T cells by agonistic anti-CD3 mAb or by HLA class II-presented peptide Ags. We show that the spatial orientation of gp120-CD4 receptor binding relative to the site of TCR engagement differentially affects TCR signaling efficiency and hence CD4(+) T cell activation. Whereas spatially and temporally linked CD4 and TCR triggering at a defined site promotes CD4(+) T cell activation by exceeding local thresholds for signaling propagation, CD4 receptor engagement by gp120-containing ICs all around the CD4(+) T cell undermine its capacity in supporting proximal TCR signaling. In vitro, gp120 ICs are efficiently captured by CD4(+) T cells and thereby render them hyporesponsive to TCR stimulation. Consistent with these in vitro results we show that CD4(+) T cells isolated from HIV(+) individuals are covered with ICs, which at least partially contain gp120, and suggest that IC binding to CD4 receptors might contribute to the progressive decline of CD4(+) T cell function during HIV-1 infection. Copyright © 2015 by The American Association of Immunologists, Inc.

Related Compounds

Structure Name/CAS No. Articles
sodium dodecyl sulfate Structure sodium dodecyl sulfate
CAS:151-21-3
Brefeldin A Structure Brefeldin A
CAS:20350-15-6
Water Structure Water
CAS:7732-18-5
Dimethyl sulfoxide Structure Dimethyl sulfoxide
CAS:67-68-5
5-(((2,5-DIOXOPYRROLIDIN-1-YL)OXY)CARBONYL)-3-OXO-3H-SPIRO[ISOBENZOFURAN-1,9'-XANTHENE]-3',6'-DIYL DIACETATE Structure 5-(((2,5-DIOXOPYRROLIDIN-1-YL)OXY)CARBONYL)-3-OXO-3H-SPIRO[ISOBENZOFURAN-1,9'-XANTHENE]-3',6'-DIYL DIACETATE
CAS:150206-05-6
Lygosporin A Structure Lygosporin A
CAS:22144-77-0
12-O-tetradecanoylphorbol-13-acetate Structure 12-O-tetradecanoylphorbol-13-acetate
CAS:16561-29-8
Direct Blue 14 Structure Direct Blue 14
CAS:72-57-1
tetracosanoic acid tryptamide Structure tetracosanoic acid tryptamide
CAS:152766-94-4
4',6-Diamidino-2-phenylindole dihydrochloride Structure 4',6-Diamidino-2-phenylindole dihydrochloride
CAS:28718-90-3